Is NRC or TMDX cheaper?

On trailing earnings, TMDX is cheaper: NRC trades at a 52.33 P/E and TMDX at 17.79.

Which has grown faster, NRC or TMDX?

Over the past five years, TMDX grew revenue faster — NRC at a 0.55% CAGR versus TMDX at 90.79%.

Does NRC or TMDX pay a bigger dividend?

NRC pays a dividend (3.08% yield) while TMDX does not currently pay one.

Is NRC or TMDX more profitable?

TMDX runs the higher net margin — NRC at 6.52% versus TMDX at 27.04%.

Which has been the better investment, NRC or TMDX?

Over the past 5-year, TMDX delivered the higher annualized total return — NRC at 6.34% versus TMDX at 14.87%. Past performance doesn't predict future results.

National Research Corporation (NRC) vs TransMedics Group, Inc. (TMDX)

TMDX leads on 8 of 13 compared metrics.

A side-by-side comparison of National Research Corporation and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

NRC

National Research Corporation

$469M

$20.81Healthcare

TMDX

TransMedics Group, Inc.

$2.33B

$77.75Healthcare

Total return — NRC vs TMDX

growth of $100 · last 7y

NRC -47.5%TMDX +202.2%TMDX compounded faster

Log scale — wide-divergence pair

NRC TMDX

NRC vs TMDX: by the numbers

•TMDX is the larger company ($2.33B vs $469M market cap).
•TMDX trades at the lower earnings multiple (17.79 vs 52.33 P/E).
•TMDX converts more revenue to profit (27.04% vs 6.52% net margin).
•TMDX grew revenue faster over the past five years (90.79% vs 0.55% CAGR).
•NRC pays a dividend (3.08% yield) while TMDX does not currently pay one.

Which is better, NRC or TMDX?

Metric tally: NRC 5 · TMDX 8

It depends on what you're optimizing for:

ValueTMDX(lower P/E)

GrowthTMDX(faster 5Y revenue CAGR)

QualityNRC(higher ROIC)

Metrics side by side

Valuation

Metric	NRC	TMDX
P/E ratio	52.33	17.79●
Forward P/E	23.65●	38.38
P/S ratio	3.29●	4.43
P/B ratio	33.79	5.70●
PEG ratio	—	0.05
EV / EBITDA	19.11●	25.25
FCF yield	3.82%	5.38%●

Profitability

Metric	NRC	TMDX
Gross margin	55.85%	59.09%●
Operating margin	14.11%	14.85%●
Net margin	6.52%	27.04%●
ROE	66.94%●	34.80%
ROIC	14.36%●	10.94%

Dividends

Metric	NRC	TMDX
Dividend yield	3.08%	—
Payout ratio	123.08%	—

Growth (annualized)

Metric	NRC	TMDX
Revenue CAGR (5Y)	0.55%	90.79%●
EPS CAGR (5Y)	-18.88%	—
FCF CAGR (5Y)	-17.24%	—
Total return CAGR (5Y)	-12.81%	14.87%●

Frequently asked

Which is better, NRC or TMDX?: It depends on your goal. value: TMDX (lower P/E); growth: TMDX (faster 5Y revenue CAGR); quality: NRC (higher ROIC). Across all compared metrics, TMDX leads 8 to 5.
Is NRC or TMDX cheaper?: On trailing earnings, TMDX is cheaper: NRC trades at a 52.33 P/E and TMDX at 17.79.
Which has grown faster, NRC or TMDX?: Over the past five years, TMDX grew revenue faster — NRC at a 0.55% CAGR versus TMDX at 90.79%.
Does NRC or TMDX pay a bigger dividend?: NRC pays a dividend (3.08% yield) while TMDX does not currently pay one.
Is NRC or TMDX more profitable?: TMDX runs the higher net margin — NRC at 6.52% versus TMDX at 27.04%.
Which has been the better investment, NRC or TMDX?: Over the past 5-year, TMDX delivered the higher annualized total return — NRC at 6.34% versus TMDX at 14.87%. Past performance doesn't predict future results.

Go deeper

Full NRC analysis Full TMDX analysis Interactive comparison tool

Dig into the metrics

National Research P/E ratio TransMedics P/E ratio National Research dividend yield TransMedics dividend yield National Research ROE TransMedics ROE National Research operating margin TransMedics operating margin National Research revenue growth TransMedics revenue growth National Research free cash flow TransMedics free cash flow

National Research & TransMedics appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.